Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 195% for ...

Specialty drugs surpass pharma sales, reaching 52% of U.S. pharmaceutical sales in 2024, driven by immunology and oncology therapies.

As of Monday, December 29, Ultragenyx Pharmaceutical Inc.’s RARE share price has dipped by 44.76%, which has investors ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

Grand Pharmaceutical Group Limited ( ($HK:0512) ) has provided an announcement. Grand Pharmaceutical Group Limited has announced that its ...

Collegium Pharmaceutical ( ($COLL) ) has issued an update. On December 30, 2025, Collegium Pharmaceutical announced the closing of its inaugural ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the ridiculously cheap stocks to buy now. As of December 26, BioMarin ...

As of Tuesday, December 30, Ultragenyx Pharmaceutical Inc.’s RARE share price has surged by 9.99%, which has investors questioning if this is right time to sell.

The firings come one month after the company voluntarily pulled a drug from the market at the request of the Food and Drug ...